title: [Anaesthesiologic problems about hyperthermic intraoperative intraperitoneal chemotherapy].
abstract: The literature considers hyperthermic intraoperative intraperitoneal chemotherapy a safe and effective procedure for peritoneal carcinomatosis, but a technical improvement is necessary. Regional chemotherapy anticipates the "downfall" of tumoral cells in the peritoneum. The Authors considered 5 patients--female, age 27-45 years, ASA 2--operated of peritonectomy in ovaric neoplasia with peritoneal metastasis. The hyperthermic intraoperative intraperitoneal chemotherapy has been made at the end of the surgery with a hot solution (43 degrees C): 3000 ml of dextrose 1.5% with mytomicina C 25 mg e cysplatino 75 mg/m2. We considered variation of emodinamic parametres (blood pressure, central venous pressure, stroke volume, etc.) and biochemical parametres (Na, K, CI-, CO2, etc.). These parametres have been correlated with some complications: fistula, anastomotic leakage, pancreatitis and postoperative bleeding.
authors.affiliation: Università degli Studi La Sapienza--Roma, Dipartimento di Chirurgia P. Valdoni.
authors.forename: L
authors.initials: L
authors.lastname: Izzo
authors.forename: F
authors.initials: F
authors.lastname: Pierannunzi
authors.forename: A
authors.initials: A
authors.lastname: Vari
authors.forename: S
authors.initials: S
authors.lastname: Riccardi
authors.forename: S
authors.initials: S
authors.lastname: Tarquini
authors.forename: A
authors.initials: A
authors.lastname: Fermariello
authors.forename: A
authors.initials: A
authors.lastname: Di Giorgio
authors.forename: A
authors.initials: A
authors.lastname: Casullo
authors.forename: M
authors.initials: M
authors.lastname: Caputo
authors.forename: U
authors.initials: U
authors.lastname: Costi
authors.forename: H
authors.initials: H
authors.lastname: Al Radhi
authors.forename: Z
authors.initials: Z
authors.lastname: Kharrub
authors.forename: S
authors.initials: S
authors.lastname: Gazzanelli
mesh_terms: D000328:Adult; D000758:Anesthesia; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006979:Hyperthermia, Induced; D007263:Infusions, Parenteral; D007430:Intraoperative Care; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage*; D010051:Ovarian Neoplasms; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D011183:Postoperative Complications
chemical_list: D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D016685:Mitomycin; D002945:Cisplatin